DIE FERRITINKONZENTRATION IM SERUM BEI VERSCHIEDENEN TYPEN DER EISENMANGELANAEMIE. = CONCENTRATION SERIQUE DE FERRITINE DANS DIVERS TYPES D'ANEMIE PAR CARENCE MARTIALEOERTEL J; GERHARTZ H.1977; DTSCHE MED. WSCHR.; DTSCH.; DA. 1977; VOL. 102; NO 32; PP. 1147-1150; ABS. ANGL.; BIBL. 29 REF.Article

ZUR BEDEUTUNG METABOLISCHER PARAMETER BEIM MORBUS HODGKIN = L'IMPORTANCE DES PARAMETRES METABOLIQUES DANS LA MALADIE DE HODGKINOERTEL J; GERHARTZ H.1976; Z. KREBSFORSCH. KLIN. ONKOL.; DTSCH.; DA. 1976; VOL. 86; NO 2; PP. 185-193; ABS. ANGL.; BIBL. 1 P.Article

ROSETTE-FORMATION WITH MOUSE RED BLOOD CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA AND LEUKEMIC NON HODGKIN'S LYMPHOMASWIRTHMUELLER R; GERHARTZ H.1980; KLIN. WSCHR.; DEU; DA. 1980; VOL. 58; NO 14; PP. 743-745; ABS. GER; BIBL. 14 REF.Article

PROLYMPHOZYTAERE LEUKAMIE: KLINISCHE, ZYTOLOGISCHE UND IMMUNOLOGISCHE BEFUNDE = LEUCEMIE PROLYMPHOCYTAIRE: CLINIQUE, CYTOLOGIE ET IMMUNOLOGIEWIRTHMUELLER R; GERHARTZ H.1980; MED. KLIN.; DEU; DA. 1980; VOL. 75; NO 11; PP. 405-409; BIBL. 22 REF.Article

Myeloid progenitors in acute non-lymphocytic leukemia: prognostic value in remissionGERHARTZ, H. H; WILMANNS, W.European journal of cancer & clinical oncology. 1986, Vol 22, Num 2, pp 135-140, issn 0277-5379Article

FERRITIN IN BONE MARROW AND SERUM IN DEFICIENCY AND IRON OVERLOADOERTEL J; BOMBIK BM; STEPHAN M et al.1978; BLUT; DEU; DA. 1978; VOL. 37; NO 3; PP. 113-117; ABS. GER; BIBL. 15 REF.Article

Cytokines can reduce clonal, CD34-positive cells in acute myeloid leukemia in vitroBRAUN, S; GERHARTZ, H. H; SCHMETZER, H. M et al.Annals of hematology (Print). 2000, Vol 79, Num 7, pp 363-373, issn 0939-5555Article

GM-CSF stimulates proliferation of clonal leukemic bone marrow cells in acute myeloid leukemia (AML) in vitroSCHMETZER, H. M; GERHARTZ, H. H; WILMANNS, W et al.Annals of hematology (Print). 1999, Vol 78, Num 10, pp 449-455, issn 0939-5555Article

Detection of acute myeloid leukemic cells in complete remission and in extramedullary sites by clonal analysesSCHMETZER, H. M; WILMANNS, W; GERHARTZ, H. H et al.Acta haematologica. 1996, Vol 96, Num 2, pp 83-87, issn 0001-5792Article

Reduction of infection rates in cancer patients associated with the use of haematopoietic growth factorsGERHARTZ, H. H.European journal of cancer. Part A. 1993, Vol 29, pp S14-S17, SUP3Conference Paper

PRINCIPLES AND PRESENT STATUS OF A PROSPECTIVE MULTICENTER STUDY ON THE CLINICAL RELEVANCE OF THE KIEL CLASSIFICATIONBRITTINGER G; SCHMALHORST U; BARTELS H et al.1981; BLUT; ISSN 0006-5242; DEU; DA. 1981; VOL. 43; NO 3; PP. 155-166; BIBL. 55 REF.Article

Recurrent spleen enlargement during cyclic granulocyte-macrophage colony-stimulating factor therapy for myelodysplastic syndromeDELMER, A; KARMOCHKINE, M; CADIOU, M et al.American journal of hematology. 1990, Vol 34, Num 1, pp 73-74, issn 0361-8609Article

Nosocomial septicemia in patients undergoing sclerotherapy for variceal hemorrhageGERHARTZ, H. H; SAUERBRUCH, T; WEINZIERL, M et al.Endoscopy (Stuttgart). 1984, Vol 16, Num 4, pp 129-130, issn 0013-726XArticle

Allogenic transplantation of blood stem cells concentrated by density gradientsGERHARTZ, H. H; NOTHDURFT, W; CARBONELL, F et al.Experimental hematology. 1985, Vol 13, Num 2, pp 136-142, issn 0301-472XArticle

Clonality analysis as a tool to study the biology and response to therapy in myelodysplastic syndromesSCHMETZER, H. M; POLECK, B; MITTERMÜLLER, J et al.Leukemia. 1997, Vol 11, Num 5, pp 660-666, issn 0887-6924Article

Philadelphia chromosome-negative acute hematopoietic malignancy: ultrastructural, cytochemical and immunocytochemical evidence of mast cell and basophil differentiationMEZGER, J; PERMANETTER, W; GERHARTZ, H et al.European journal of haematology. 1990, Vol 44, Num 1, pp 74-77, issn 0902-4441Article

Gene rearrangements in bone marrow cells of patients with acute myelogenous leukemiaSCHMETZER, H. M; BRAUN, S; WIESNER, D et al.Acta haematologica. 2000, Vol 103, Num 3, pp 125-134, issn 0001-5792Article

Enhanced endogenous leukotriene biosynthesis in patients treated with granulocyte-macrophage colony-stimulating factorDENZLINGER, C; KAPP, A; GRIMBERG, M et al.Blood. 1990, Vol 76, Num 9, pp 1765-1770, issn 0006-4971Article

Cooperative trials of hodgkin's lymphoma in the federal republic of GermanyDIEHL, V; PFREUNDSCHUH, M; LOÊFFLER, M et al.Journal of cancer research and clinical oncology. 1990, Vol 116, Num 1, pp 106-108, issn 0171-5216, 3 p.Conference Paper

CHOP and COPBLAM chemotherapy for diffuse large cell non-Hodgkin's lymphomas: a retrospective comparisonGERHARTZ, H. H; THIEL, E; HILLER, E et al.Hematological oncology. 1988, Vol 6, Num 1, pp 13-19, issn 0278-0232Article

Epstein-Barr virus-positive recipient type B-cells survive in a complete chimera after allogeneic bone-marrow transplantationGERHARTZ, H. H; MITTERMÜLLER, J; ANAND RAGHAVACHAR et al.International journal of cancer. 1988, Vol 42, Num 5, pp 672-676, issn 0020-7136Article

Differential activation of the endogenous leukotriene biosynthesis by two different preparations of granulocyte-macrophage colony-stimulating factor in healthy volunteersDENZLINGER, C; TETZLOFF, W; GERHARTZ, H. H et al.Blood. 1993, Vol 81, Num 8, pp 2007-2013, issn 0006-4971Article

Spontaneous Epstein-Barr virus transformed B-cell line sharing the identical immunoglobulin gene rearrangement with acute myeloid leukemiaGERHARTZ, H. H; BARTRAM, C. R; RAGHAVACHAR, A et al.Blood. 1989, Vol 73, Num 3, pp 684-687, issn 0006-4971Article

Subclassification of diffuse large B-cell lymphomas according to the Kiel classification: Distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factorENGELHARD, M; BRITTINGER, G; GRIESSER, H et al.Blood. 1997, Vol 89, Num 7, pp 2291-2297, issn 0006-4971Article

Interleukin-3 plus low-dose cytosine arabinoside for advanced myelodysplasia : A pilot studyGERHARTZ, H. H; ZWIERZINA, H. H; WALTHER, J et al.Cancer investigation. 1996, Vol 14, Num 4, pp 299-306, issn 0735-7907Article